Press releases

8 May, 2013

NeuroVive starts Investor Relations Partnership with Laika Consulting

NeuroVive Pharmaceutical AB (publ) has initiated a collaboration within investor relations communication with Laika Consulting, a company that specializes in helping companies and other entities with ...

10 April, 2013

NeuroVive First Day of Trading on NASDAQ OMX Stockholm

Lund (Sweden) – April 10, 2013, NeuroVive Pharmaceutical AB (publ), a leading mitochondrial medicine company, announces that its admission to NASDAQ OMX Stockholm will become effective and tradi ...

25 March, 2013

NeuroVive: NeuroVive Admitted to Trading on NASDAQ OMX Stockholm

Note: This is an English version of a press release communicated by NeuroVive 2013-03-22.

22 March, 2013

NeuroVive: 600th heart attack patient recruited into Phase III CicloMulsion® CIRCUS trial

Lund (Sweden) - March 22, 2013, NeuroVive, a leading mitochondrial medicine company, announces that the 600th patient has been recruited to a pivotal Phase III European, multi-center trial (CIRCUS tri ...

18 March, 2013

NeuroVive: NeuroVive appoints Anna Malm Bernsten and Boel Flodgren to its Board of Directors

Se nyheten från NeuroVive (http://www.aktietorget.se/pressdocs/NeurovivePharmaceutical/64884/NeuroVive__NVP_20130318_2.PDF) Lund (Sweden) - March 18, 2013, NeuroVive Pharmaceutical AB, a leading mitoc ...

11 March, 2013

NeuroVive: NeuroVive acquires highly potent, novel cyclophilin inhibitors from Biotica

Lund (Sweden) - March 11, 2013, NeuroVive, a leading mitochondrial medicine company, announces it has completed the acquisition of a portfolio of novel cyclophilin inhibitors, technology platform asse ...

4 March, 2013

NeuroVive: NeuroVive to present at the 3rd Annual Traumatic Brain Injury Conference in Washington DC

Lund (Sweden) - March 4th, 2013, NeuroVive Pharmaceutical AB, a leading mitochondrial medicine company, announces that Mikael Brönnegård, Chief Executive Officer, will present an overview of its clini ...

1 February, 2013

NeuroVive: NeuroVive appoints Chief Operating OfficerView news item from NeuroVive

Note: This is an English version of a press release communicated by NeuroVive 2013-02-01